Jane Street’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Jane Street’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,165	Closed	-$42.2K	–	10446
2024 Q4	$42.2K	Buy	+1,165	New	+$32.4K	﹤0.01%	9010

Other funds holding RVPH

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's RVPH Position: Q1 2026 in Review

Jane Street sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 44,737 shares — an estimated $250K sold.

Jane Street first reported a position in RVPH in Q3 2022 and held it in 6 quarters. The position peaked at $250K in Q4 2025. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

Jane Street reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
Jane Street sold 44,737 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $250K.
Jane Street first reported a position in REVIVA PHARMA HLDGS INC in Q3 2022 and held it in 6 quarters.
Jane Street's REVIVA PHARMA HLDGS INC position peaked at $250K in Q4 2025.
35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.